🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/02/2016 | 114,96 | 121,20 | 113,20 | 119,32 | +3,08% | 6,96% | 669.300 |
| 08/02/2016 | 116,82 | 119,75 | 114,50 | 115,75 | -2,28% | 4,49% | 979.000 |
| 05/02/2016 | 121,20 | 122,55 | 116,60 | 118,45 | -3,50% | 4,91% | 1.186.300 |
| 04/02/2016 | 121,87 | 125,98 | 119,80 | 122,75 | -0,02% | 5,07% | 667.400 |
| 03/02/2016 | 122,39 | 123,52 | 116,60 | 122,77 | +0,07% | 5,65% | 732.500 |
| 02/02/2016 | 124,29 | 125,40 | 119,74 | 122,68 | -2,33% | 4,55% | 725.600 |
| 01/02/2016 | 123,08 | 126,53 | 121,99 | 125,61 | +1,97% | 3,69% | 944.500 |
| 29/01/2016 | 122,63 | 125,54 | 121,27 | 123,18 | +0,32% | 3,48% | 784.700 |
| 28/01/2016 | 126,74 | 127,44 | 120,07 | 122,79 | -2,05% | 5,82% | 817.700 |
| 27/01/2016 | 127,89 | 129,19 | 124,22 | 125,36 | -1,79% | 3,89% | 655.400 |
| 26/01/2016 | 127,26 | 129,72 | 124,41 | 127,64 | +0,55% | 4,17% | 800.100 |
| 25/01/2016 | 128,48 | 129,41 | 126,26 | 126,94 | -1,93% | 2,45% | 925.200 |
| 22/01/2016 | 128,23 | 130,60 | 125,97 | 129,44 | +2,89% | 3,61% | 643.100 |
| 21/01/2016 | 129,61 | 131,23 | 124,69 | 125,81 | -2,18% | 5,05% | 931.900 |
| 20/01/2016 | 127,43 | 131,14 | 124,08 | 128,61 | -0,43% | 5,54% | 973.900 |
| 19/01/2016 | 134,54 | 136,23 | 126,78 | 129,17 | -2,95% | 7,02% | 671.200 |
| 15/01/2016 | 133,44 | 135,97 | 120,52 | 133,10 | -2,29% | 11,58% | 1.085.300 |
| 14/01/2016 | 136,83 | 138,78 | 132,84 | 136,22 | +0,29% | 4,34% | 944.500 |
| 13/01/2016 | 143,34 | 144,65 | 134,81 | 135,82 | -5,17% | 6,86% | 642.700 |
| 12/01/2016 | 141,03 | 145,26 | 137,42 | 143,23 | +3,53% | 5,56% | 1.180.900 |
| 11/01/2016 | 141,95 | 143,00 | 135,93 | 138,34 | -2,23% | 4,98% | 695.400 |
| 08/01/2016 | 146,90 | 148,45 | 141,21 | 141,50 | -2,02% | 4,93% | 623.400 |
| 07/01/2016 | 144,43 | 148,59 | 142,49 | 144,42 | -1,84% | 4,22% | 727.100 |
| 06/01/2016 | 148,91 | 150,39 | 145,08 | 147,12 | -1,95% | 3,57% | 986.400 |
| 05/01/2016 | 156,38 | 159,96 | 149,16 | 150,04 | -3,54% | 6,91% | 855.800 |
| 04/01/2016 | 154,23 | 156,28 | 152,22 | 155,54 | -0,68% | 2,63% | 807.500 |
| 31/12/2015 | 157,78 | 159,05 | 156,46 | 156,61 | -1,21% | 1,64% | 358.500 |
| 30/12/2015 | 159,26 | 160,65 | 158,39 | 158,53 | -0,44% | 1,42% | 281.700 |
| 29/12/2015 | 161,87 | 162,37 | 158,01 | 159,23 | -1,01% | 2,69% | 388.400 |
| 28/12/2015 | 159,99 | 163,22 | 158,00 | 160,86 | -0,03% | 3,26% | 297.400 |